-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development

Dow Jones·09/24/2026 11:00:00

Please log in to view news